GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: May 15, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-repurchase
Related Tickers: GSK
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on May 15, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases, which is common for publicly traded companies.
Key Players & Entities
- GSK plc (company) — The company making the share purchase.
- Citigroup Global Markets Limited (company) — The corporate stockbroker acting on behalf of GSK plc.
- May 2025 (date) — The reporting period for the transaction.
FAQ
What is the specific number of GSK plc ordinary shares purchased?
The filing states that a 'number' of ordinary shares were purchased, but does not specify the exact quantity.
What is the total dollar amount spent on the share repurchase?
The filing does not disclose the total dollar amount of the share repurchase.
When did the share repurchase transaction occur?
The transaction is reported for the month of May 2025.
Who is acting as GSK plc's corporate stockbroker for this transaction?
Citigroup Global Markets Limited is acting as GSK plc's corporate stockbroker.
What is the par value of GSK plc's ordinary shares?
The ordinary shares have a par value of 31 1/4 pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 15, 2025 regarding GSK plc (GLAXF).